Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMany people notice their appetite creeping back in the days just before their next Wegovy injection — and yes, this is a recognised pattern. Semaglutide has a half-life of roughly one week, meaning blood levels do fall gradually as the week progresses. That said, for most people the effect is steady enough that weekly dosing works well, and end-of-week dips are often manageable with a few practical adjustments. These are prescription-only medicines, and a prescriber is the right person to assess whether what you're experiencing calls for a clinical change.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Picture this: it's Thursday evening, your Wegovy injection was on Monday, and the appetite suppression that felt so solid on Tuesday has softened noticeably. You're not imagining it. Semaglutide, the active ingredient in Wegovy, has a half-life of around seven days. That means roughly half of the dose you injected is still circulating a week later, but the other half has cleared, and levels are lower than they were on day one or two. Blood concentrations follow a predictable curve: rising for a day or so after injection, plateauing through the middle of the week, then declining. By day six or seven, you're at the trough.
The STEP 1 trial, published in the New England Journal of Medicine, studied semaglutide 2.4mg weekly over 68 weeks and found average weight loss of around 15%. That result was built on the same once-weekly schedule, trough and all, so the pharmacokinetics were accounted for from the start. The trough doesn't cancel the medicine's effect; it just means the effect isn't uniform across every hour of the week. For most people at maintenance dose, the dip is barely perceptible. For others, especially earlier in treatment, it's noticeable enough to be frustrating, and if you want to understand whether Wegovy wears off over the course of the week and why, it helps to look at how the blood concentration curve behaves day by day.
The NHS semaglutide medicines page notes that nausea and appetite effects are most pronounced early in treatment and tend to settle, which is also broadly true of the weekly fluctuation pattern. As your system adjusts over weeks and months, the highs and lows of appetite through the week often level out.
If you're on a lower dose (0.25mg or 0.5mg during the early titration steps) the trough effect can feel sharper. The medicine hasn't yet reached its full working concentration in your system (known as steady-state, which builds over several weeks of consistent dosing), and the therapeutic window is narrower at lower doses. It's a bit like the difference between a full reservoir and one that's still filling: the buffer against trough is smaller.
This is one reason the titration schedule exists. The path from 0.25mg through to the 2.4mg maintenance dose isn't just about tolerability; higher doses maintain a broader therapeutic effect across the whole week, which can smooth out those end-of-week fluctuations. If you're still on a lower dose and finding the last couple of days difficult, that experience is worth logging and sharing at your next clinical review. A prescriber can look at where you are in the titration schedule and whether a step is appropriate. Jumping ahead isn't the answer (the gradual pace protects against side effects) but it does mean relief is usually time-limited rather than permanent.
Some people also find that injection day matters. Injecting on a Friday means the trough lands mid-week, which might suit your schedule better than hitting it on a weekend. Switching injection day is straightforward in principle, but it's a conversation for your prescriber rather than a unilateral change, since the gap between doses needs to stay consistent. If you're considering treatment and want to understand how this fits your routine, you can read more about how Wegovy works before deciding.
The end-of-week dip is real, but it's workable. A few things consistently help.
Timing is the first lever. Injecting on the same day, at roughly the same time, every week keeps the curve predictable. The Wegovy pen comes in a discreet, plain box via next-working-day DPD delivery, so keeping a spare in the fridge means injection day stays on track without scrambling. Consistency matters more than the specific day you choose.
Protein at meals on days six and seven does more work than it does mid-week. It's slower to digest and blunts appetite more durably than carbohydrate-heavy meals. Staying well hydrated helps too, it's easy to misread thirst as hunger, and that misreading is more likely when appetite suppression is lighter.
Planning ahead is underrated. If you know Thursday and Friday are your hungrier days, prepare higher-protein meals for those days in advance. That's not a willpower exercise; it's working with the pharmacology you already understand. People who notice that Wegovy seems to wear off by the end of the week often find that structuring those final days around higher-protein meals makes the trough much more manageable. Some people find the broader question of whether Wegovy effects fade over time also worth exploring, since long-term effect and weekly fluctuation are related but different questions.
For cost context, it's worth understanding what private treatment actually includes. A look at how Wegovy is priced in the UK sets out what an all-in private prescription typically covers (clinical review, prescription, and aftercare) which matters when the temptation to cut corners is real.
Not every end-of-week change needs clinical input. A mild softening of appetite suppression, managed with the steps above, is within normal range. But some patterns are worth flagging promptly.
If the last two days of the week reliably feel like you've lost all appetite control (or if you're compensating with eating patterns that feel disruptive) that's clinical information. It may mean the current dose is insufficient for your physiology, or that titration can safely continue. A prescriber can also check whether injection technique is consistent: injecting into scar tissue or varying between abdomen, thigh, and upper arm without rotation can affect absorption and make the curve less predictable than it should be.
Similarly, if the dip is accompanied by the return of any symptoms you started treatment to address, that's worth a conversation. The day-by-day pattern of semaglutide's action can vary between individuals, and a prescriber who knows your history is better placed to interpret it than a general guide can be. At nume, our clinical team reviews each repeat order before it's dispensed, which creates a natural checkpoint for exactly this kind of question, no need to raise it separately. If you'd like a prescriber to look at your current experience, start a free consultation and get a same-day clinical review.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.